These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7345350

  • 1. Evaluation of two combination chemotherapies in previously untreated non Hodgkin's lymphoma.
    Somoza N, Pavlovsky S, Suárez A, Morgenfeld M, Besuschio SC, Bezares R, Quiroga Micheo E, Lein JM, De María H.
    Medicina (B Aires); 1981; 41 Suppl():35-43. PubMed ID: 7345350
    [No Abstract] [Full Text] [Related]

  • 2. [Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy].
    Sampi K, Honda T, Hattori M.
    Rinsho Hoshasen; 1983 Jun; 28(6):673-7. PubMed ID: 6688641
    [No Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
    Pavlovsky S, Morgenfeld M, Somoza N, Magnasco J, Sackmann Muriel F, Cavagnaro F, Suárez A, Barros CA, Saslavsky J, Garay G, Palau M, Besuschio SC.
    Medicina (B Aires); 1981 Jun; 41 Suppl():15-21. PubMed ID: 6896551
    [No Abstract] [Full Text] [Related]

  • 4. [Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols].
    Płuzańska A, Krykowski E, Robak T, Oliskiewicz W, Polkowska E, Dowgier I, Hyjek E.
    Pol Tyg Lek; 1982 Sep 27; 37(36):1049-53. PubMed ID: 6189105
    [No Abstract] [Full Text] [Related]

  • 5. Deferral of initial therapy for advanced indolent lymphomas.
    Portlock CS.
    Cancer Treat Rep; 1982 Mar 27; 66(3):417-9. PubMed ID: 7037178
    [No Abstract] [Full Text] [Related]

  • 6. [Chemotherapy of malignant lymphoma].
    Horikoshi N, Ogawa M.
    Gan To Kagaku Ryoho; 1982 Nov 27; 9(11):1903-10. PubMed ID: 6985187
    [Abstract] [Full Text] [Related]

  • 7. [Present status and future problems in non-Hodgkin's lymphoma. III. On the chemotherapy of non-Hodgkin's lymphoma (author's transl)].
    Sakano T.
    Rinsho Ketsueki; 1981 Feb 27; 22(2):159-77. PubMed ID: 7031290
    [No Abstract] [Full Text] [Related]

  • 8. [Maintenance treatment in non-Hodgkin's malignant lymphoma].
    Geib KR, Guran M, Sighetea E.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983 Feb 27; 35(5):397-402. PubMed ID: 6143357
    [No Abstract] [Full Text] [Related]

  • 9. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 May 01; 21(9):1734-9. PubMed ID: 12721249
    [Abstract] [Full Text] [Related]

  • 10. [Results of treatment of advanced cases of non-Hodgkin's-lymphoma (author's transl)].
    Kotlarek-Haus S, Nowicka J, Gabryś K, Starzyk H, Becker M, Kaiser A, Hinrle Z.
    Przegl Lek; 1979 May 01; 36(7):567-71. PubMed ID: 504706
    [No Abstract] [Full Text] [Related]

  • 11. A comparative study with COP and COP-Bleo combination chemotherapy in advanced (non-Hodgkin's) lymphomas.
    Kaku K, Inoue M, Fujii S, Ishida Y, Hiroshige Y, Shinohara K, Nakashima K, Matsumoto N, Kaneko T.
    Nihon Ketsueki Gakkai Zasshi; 1983 Jul 01; 46(4):940-6. PubMed ID: 6195877
    [No Abstract] [Full Text] [Related]

  • 12. Role of combined-modality therapy in the curative management of advanced-stage "favorable" non-Hodgkin's lymphomas.
    Kinsella TJ.
    Cancer Treat Rep; 1982 Mar 01; 66(3):421-5. PubMed ID: 7037179
    [No Abstract] [Full Text] [Related]

  • 13. [Comparative study of two drug combination in non-Hodgkin's lymphoma (author's transl)].
    Somoza N, Morgenfeld MC, Magnasco J, Pavlovsky S, Cavagnaro FJ, Saslavsky J, de Maria H, Macchi A, Suárez A.
    Sangre (Barc); 1978 Mar 01; 23(4):418-25. PubMed ID: 705564
    [No Abstract] [Full Text] [Related]

  • 14. [Do non-localized non-Hodgkin's lymphoma and acute lymphoblastic leukemia with large tumor masses require the same therapy?].
    Pastore G, Cordero di Montezemolo L, Boschis MP, Ghibaudo P, Saracco P, Miniero R, Madon E, Forni M, Saitta M.
    Haematologica; 1985 Mar 01; 70(4):313-8. PubMed ID: 3935529
    [No Abstract] [Full Text] [Related]

  • 15. [VCP therapy for non-Hodgkin's lymphoma advanced more than stage IIB].
    Kuraishi Y, Ozeki H, Takasaki N, Mashizu N, Nagamine D, Usui N, Yamazaki H, Nakamura T, Aiba K, Yokoyama K.
    Rinsho Ketsueki; 1984 Nov 01; 25(11):1731-7. PubMed ID: 6543455
    [No Abstract] [Full Text] [Related]

  • 16. [Therapy of non-Hodgkin's lymphoma].
    Schaadt M, Plaumann L, Diehl V.
    Dtsch Med Wochenschr; 1984 Feb 17; 109(7):261-5. PubMed ID: 6199176
    [No Abstract] [Full Text] [Related]

  • 17. "Good risk" non-Hodgkin lymphomas: approaches to management.
    Portlock CS.
    Semin Hematol; 1983 Jan 17; 20(1):25-34. PubMed ID: 6342139
    [No Abstract] [Full Text] [Related]

  • 18. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Hehn ST, Miller TP.
    Curr Hematol Rep; 2004 Jan 17; 3(1):17-26. PubMed ID: 14695845
    [Abstract] [Full Text] [Related]

  • 19. [Hematologic tumors].
    Ogawa M.
    Gan To Kagaku Ryoho; 2003 Oct 17; 30(10):1416-21. PubMed ID: 14584273
    [Abstract] [Full Text] [Related]

  • 20. [Chemotherapy for non-Hodgkin's lymphoma].
    Kuraishi Y, Usui N, Dobashi N.
    Gan To Kagaku Ryoho; 1998 Dec 17; 25(14):2210-6. PubMed ID: 9881077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.